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and investigate them for biological and pharmacological 
activities. The key starting materials, 1-H-indole 2-3 
dione and 2-aminothiazole, were refluxed in the presence 
of alcohol and glacial acetic acid to get Schiff base 3 
(1’-3’thiazole 2-yl imino) 1-3 dihydro 2-H-indole-2-
one (A); mannich bases are prepared with different 
secondary amines in the presence of formaldehyde (A1-
A6). Meanwhile, Spiro isatin derivatives are prepared with 
Azetidine (Aa) and thiazolidone (Ab) in the presence of 
chloroacetyl chloride (Cl-CH2-CO-Cl) and thioglycolic acid 
(SH-CH2-COOH).
MATERIALS AND METHODS
Melting points are recorded in open capillary tubes and 
are uncorrected. The IR spectra (KBr) were recorded on a 
INTRODUCTION
Isatin (1-H indole 2-3 dione) are synthetically versatile 
substances that are employed for the synthesis of a large 
variety of heterocyclic compounds, including some drugs. 
Over the years, the molecules with isatin show diversified 
biological activities, e.g. antibacterial,[1] anticonvulsants,[2] 
antiviral[3] and antitubercular[4] activities. Schiff and 
mannich bases of isatin have shown good antimicrobial 
activities against gram-negative bacteria and fungi.  [3] 
A number of Spiro compounds derived from isatin 
are important pharmacophores and exhibit promising 
biological activities,[5] such as analgesic, fungicidal and 
anti-inflammatory activity. Thiazole and its derivatives are 
reported to show good antibacterial, anti-inflammatory and 
analgesic[6] activity. Hence, it was thought worthwhile to 
synthesize new Schiff, mannich and Spiro isatin derivatives 
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Schiff bases of isatin with aminothiazole, its N-mannich bases and Spiro isatin derivatives were synthesized. 
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analysis. Antimicrobial evaluation was performed by the agar diffusion method against four pathogenic bacteria 
and two pathogenic fungi. Anti-inflammatory activity was tested by carragenin-induced rat paw edema and 
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SHIMADZU FTIR-8300,  spectrophotometer, Japan. The 
H-NMR spectra were recorded on a Bruker Advance-400 
MHz spectrometer, USA. Purity of the compounds was 
checked by Thin layer chromatography For analgesic, 
anti-inflammatory activity studies, adult healthy albino rats 
(Swiss strain) of either sex weighing 80–120 g were used. 
All the animals were maintained under standard conditions 
and had access to pelleted animal feed and water. The study 
protocol was approved by the Institutional Animal Ethics 
Committee.
Synthesis[7] of 3(1’-3’Thiazole-2-yl Imino) 1-3 Dihydro-
2H Indole-2-One (A)
Equimolar quantity of isatin and 2-amino thiazole was 
taken in a round bottom flask, dissolving the content with 
a sufficient amount of ethanol and two to three drops of 
glacial acetic acid was added. The content was refluxed 
for 4–5 h and then poured into ice cold water. The solid 
obtained was filtered, dried and recrystallized from ethanol.
Synthesis[7] of 1[(Diphenyl Amino) Methyl]-3-(1’-3’ 
Thiazole-2-yl Imino) 1-3 Dihydro-2H Indole-2-One 
(A1)
To a slurry containing A (0.003 mol), ethanol (5 ml) and 
37% formalin (1 ml), diphenylamine (0.003 mol) was added 
slowly with good stirring. The reaction mixture was cooled 
and allowed to stand at room temperature for 1 h, with 
occasional shaking. Then, it was warmed on a steam bath 
for 15 min, cooled and the product was recovered. The 
product was recrystallized from chloroform–methanol 
(1:1) mixture.
The compounds 1(piperazin-1-yl) methyl-3-(1’-3’ 
thiazole-2-yl imino) 1-3 dihydro-2H indole-2-one (A2), 
1[(dicyclohex-yl) methyl]-3-(1’-3’ thiazole-2-yl imino) 
1-3 dihydro-2H indole-2 one (A3), 1[(dimethylamino) 
methyl]-3-(1’-3’ thiazole-2-yl imino) 1-3 dihydro-2H 
indole-2 one (A4), 1-[(diethylamino) methyl]-3-(1’-3’ 
thiazole-2-yl imino) 1-3 dihydro-2H indole-2 one (A5) 
and 1-[(morpholin-4”yl) methyl]-3-(1’-3’ thiazole-2-yl 
imino) 1-3 dihydro-2H indole-2 one (A6) were prepared 
by following a similar procedure.
Synthesis of 3’Chloro-1-(1”-3”Thiazo-2-yl) 4’-H-Spiro 
[Azetidine-2, 3’Indole] 2’4-(1-H) Di One (Aa)[8]
Compound 3(1’-3’thiazole-2-yl imino) 1-3dihydro-2H 
indole-2-one (A) (0.01mol) was dissolved in 1-4 dioxan (20 
ml) in a 100 ml beaker and trimethyl amine (0.001 mol) was 
added to it. Then, the contents of the beaker were stirred 
and chloroacetyl chloride (0.001 mol) was added slowly, 
continuing stirring of contents of the beaker for 8 h. The 
resulting solution was poured into ice cold water, filtered, 
dried, recrystallized from chloroform–methanol (1:1) and 
added in a round bottom flask. The content of the flask 
was refluxed for 12–14 h, the product was recovered in ice 
cold water, filtered, dried and finally recrystallized from 
chloroform–methanol (1:1) mixture.
Synthesis of 3’Chloro-1-(1”-3”Thiazo-2-yl) 4’-H-Spiro 
[Indole-3,2-(1,3) Thiazolidine] 2’4-(1-H) Di One (AB)[5]
Equimolar quantity of compound A and thioglycollic acid 
was dissolved in a round bottom flask. Then, 1,4-dioxane 
and a pinch of zinc chloride was added to it. The contents 
of the mixture were refluxed for 12–14 hr, concentrating 
the content of the flask, and poured into ice cold water. 
The solid mass was collected and dried. The product was 
recrystallized from chloroform–methanol mixture (1:1).
Antimicrobial activity
The in vitro antimicrobial activity[9] was carried out against 
24-h-old cultures of microorganisms by the cup–plate 
method. Compound A1-A6 and Aa, Ab were tested against 
four pathogenic bacteria, Pseudomonas mirebelis, Pseudomonas 
auroginosa, Escherichia coli and Staphylococcus aureus. The 
antifungal activity was tested against Aspergillus niger and 
Candida albicans. Ampicillin and cotrimoxazole was taken as 
an internal standard for antibacterial and antifungal activity, 
respectively. The compound was tested at a concentration 
of 100 µ/ml in DMF against all organisms. The zone of 
inhibition was compared with the standard drug after 24-h 
incubation at 37°C for antibacterial and 48 h at 25°C for 
antifungal activity.
Analgesic activity
The analgesic activity[10] was evaluated by the acetic acid-
induced writhing test[6] using adult Swiss albino mice of 
either sex. In this method, mice are made to writhe by a 
simple intraperitonial injection of 0.6% v/v aqueous acetic 
acid (0.1 ml/kg). Test substances were administered 30 min 
before the injection of acetic acid. The number of writhes 
(full extension of hind paws) was recorded.
Anti-inflammatory activity
The anti-inflammatory activity[10] was evaluated by rat paw 
edema. Edema represents the early phase of inflammation 
and carragenin-induced paw edema is the simplest 
and most widely used method[8] for studying the anti-
inflammatory activity of the chemical compounds. This 
method is based on the plethysmographic measurement 
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of carragenin-induced acute rat paw edema. For this study, 
Wister rats of either sex, weighing between 80 and 100 g 
were divided into 10 groups of five animals each. Group1 
serves as a solvent control, and received 0.5% Carboxy 
Methyl Cellulose in normal saline orally. Group 2 received 
indomethacin (10 mg/kg) in solvent as a standard. Groups 
3–10 received test drugs at a dose of 100 mg/kg orally. 
These drugs were administered 1 h before the injection 
of an irritant, carragenin. After 1 h, all the animals were 
injected subcutaneously with a suspension of carragenin in 
CMC solution (0.1 ml) to the left hind paw in the subplantar 
region and the paw volume was measured immediately. 
After 3 h, the paw volume was measured for the control, 
standard and test groups. Percentage inhibition of paw 
volume was calculated.
RESULTS AND DISCUSSION
The structures of newly synthesized compounds were 
elucidated by IR, 1H-NMR and elemental analysis and are 
reported as follows:
The IR spectrum of A in KBr (in cm-1): 3446 (NH str), 
1728 (C=O), 1610.95 (C=N), 1469.01 (CH=CH of Ar), 
1096.66 (C-S-C).
1H-NMR of A (δ values): 11.04 (S, 1H, NH), 6.89–7.61 
(m, Ar-H), 3.39 (1H,CH), 3.16 (1H, CH).
IR of A1 (in cm-1): 2890 (CH2), 1730 (C=O), 1670 (C=N), 
1459.37 (CH=CH), 1200 (C-N), 1090 (C-S-C), 766.888 
(C=C aromatic hydrocarbon).
1H-NMR of A1 (δ values): 6.89–7.09 (m, Ar-H), 2.50 (S.2H, 
N-CH2), 3.38 (S, 2H, CH of thiazole).
IR of A2 (in cm-1): 2832 (CH2), 1720 (C=O), 1609 (C=N), 
1480 (CH=CH), 1363 (C-N), 1164.30 (C-S-C str), 3305 
(N-H).
1H-NMR of A2 (δ values): 6.89–7.92 (m, Ar-H), 4.38 (S, 1H, 
N-H), 3.06–3.38 (δ, 1H, CH), 1.23 (t, 2H, CH2 piperazine).
IR of A3 (in cm-1): 2946 (CH), 2854 (C-H), 1718.84 (C=O), 
Table 1: Characterization data of the synthesized compounds
Compounds M.P (0C) Yield% Molecular formula Found (calculated) %
C H N
A1
A2
A3
A4
A5
A6
Aa
Ab
108–110
238–240
110–114
220–223
252–254
248–250
340–342
343–344
59
68
72
72
61
65
65
62
C24H18N4OS
C16H17N5OS
C24H30N4OS
C14H14H4OS
C16H18N4OS
C16H16N4O2S
C13H8N3SO2Cl
C13H9N3S2O
58.52 (58.72)
69.90 (70.22)
67.01 (68.21)
58.60 (58.72) 
61.01 (61.12)
58.71 (58.82) 
50.88 (51.47)
51.12 (51.47)
5.03 (5.23)
4.21 (4.41) 
6.89 (7.16)
4.81 (4.93)
5.72 (5.77)
4.80 (4.91)  
2.47 (2.64)
2.83 (2.99)
21.12 (21.39) 
13.40 (13.65)
12.89 (13.28)
19.40 (19.57)
17.81 (17.82) 
16.99 (17.06) 
13.53 (13.74)
3.63 (13.85)
Table 2: Results of antimicrobial activity
Compounds Zone of inhibition* (mm)
Antibacterial activity Antifungal activity
P. mirebelis P. auroginosa E. coli S. aureus A. niger C. albicans
A1
A2
A3
A4
A5
A6
Aa
Ab
Ampicillin
CotrimoxazoleDMF
12
13
10
11.1
11
12.2
15.2
13.5
23
-
14.2
12.9
10.3
11
11.2
12.5
17
16.1
22.5
10
10
11.2
10
13.6
14
20
17.5
24
-
9.5
8.3
9.8
8.8
9.3
9.1
10
10
26
-
22.2
21
23
17
21
22.9
5
24.3
27.6
-
17.3
16.5
20
17.8
15.3
19
21.2
20
28
-
*average of three readings.
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Table 3: Analgesic activity of the compounds
Compound code Dose 
(mg/kg)
Number of 
writhing 
movements
% of protection
0.5% CMC
Indomethacin
A1
A2
A3
A4
A5
A6
Aa
Ab
-
10
100
100
100
100
100
100
100
100
58.8 ± 0.95
11.2 ± 4.32**
37.2 ± 3.21*
39.2 ± 3.48
30.8 ± 2.23*
36.6 ± 2.97*
39.5 ± 3.27
27.5±2.85** 
17.8 ± 2.19**
19.3 ± 2.98**
-79.5632.1128.46
43.7933.2127.91
49.8167.5164.78
Values are expressed as mean ± SE (n = 6). *P<0.05, **P<0.01 and ***P<0.001 
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1647.58 (C-N), 1517 (C=N), 1458 (CH=CH of Ar), 1105 
(C-S-C).
IR of A5 (in cm-1): 2942 (CH2), 1735 (C=O), 1676 (C=N), 
1654 (C-N), 1542 (CH=CH of Ar), 1042 (C-S-C str), 758 
(C=C).
IR of A6 (in cm-1): 2396 (CH2 str), 1718 (C=O), 1560 (C-N 
str), 1654 (C=N), 1542 (CH=CH of Ar), 1108 (C-S-C str), 
1005 (C-O-C str), 717 (C=C Ar).
IR of Aa (in cm-1): 3445 (NH str), 1720 (C=O), 1710 
(C=O), 1640 (C-N), 649 (C-Cl).
1H-NMR Aa: 11.08 (s, 1H, NH), 6.93–7.79 (m-Ar-H), 3.39 
(δ,1H, CH of thiazole), 2.27 (s, 1H, CH, CH2Cl).
IR of Ab (in cm-1): 3442 (NH str), 1724 (C=O), 1708 
(C=O), 1645 (C-N), 1090 (C-S-C).
1H-NMR of Ab (δ values): 11.08 (s, 1H, NH), 6.71–7.78 
(m-Ar-H), 3.39 (δ, 1H, CH of thiazole), 2.50 (s, 2H, CH2).
The characterization of synthesized compounds is given 
in Table 1. Analytical data of the compounds supports the 
proposed structures.
Results of antimicrobial activity, analgesic activity and anti-
inflammatory activity are shown in Tables 2–4, respectively. 
The results of the antimicrobial activity revealed that the 
compounds A3, A5, A6, Aa and Ab were found to be active 
against bacteria and fungi. The compounds A3, A6, Aa and 
Ab showed significant analgesic activity, with percentage 
of inhibition of 43.69, 49.81, 67.51, 64.78, respectively, as 
compared to indomethacin, with percentage inhibition of 
79.56. The compounds Aa, A6, Ab, showed considerable 
anti-inflammatory activity, having percentage protection 
of 38.77, 32.65 and 36.73 as compared with indomethacin, 
having percentage protection value of 46.93.
Table 4: Anti-inflammatory activity of the compounds
Compound code Group Volume of mercury displaced (ml)
1 h (% of protection) 2 h (% of protection) 3 h (% of protection)
0.5% CMC
Indomethacin
A1
A2
A3
A4
A5
A6
Aa
Ab
1
2
3
4
5
6
7
8
9
10
0.49 ± 0.013
0.26 ± 0.012 (46.93)
0.41 ± 0.025* (16.32)
0.48 ± 0.041 (2.02)
0.32 ± 0.041** (34.69)
0.47 ± 0.033 (4.08)
0.46 ± 0.043 (6.12)
0.33 ± 0.032** (32.65)
0.30 ± 0.043** (38.77)
0.31 ± 0.041** (36.73)
0.55 ± 0.033
0.37 ± 0.022 (32.72)
0.54 ± 0.029 (1.81)
0.54 ± 0.012 (1.81)
0.53 ± 0.034 (3.36)
0.52 ± 0.036  (5.54)
0.54 ± 0.012  (1.81)
0.39±0.031* (29.09)
0.37±0.013** (32.72)
0.38±0.033** (30.90)
0.59 ± 0.022
0.39 ± 0.012 (33.89)
0.45 ± 0.022** (23.72)
0.57 ± 0.032 (3.38)
0.46±0.030** (22.03)
0.43±0.032** (27.11)
0.56 ± 0.032 (1.69)
0.46±0.016** (22.03)
0.45±0.041*** (23.72)
0.46±0.061** (22.03)
Values are expressed as mean ± SE (n = 6). *P<0.05, **P<0.01 and ***P<0.001 compared with vehicle control (ANOVA followed by Dunnet’s t-test).
Thus, it is observed that the synthesized compounds 
showed promising antimicrobial, analgesic and anti-
inflammatory activities. Further studies are needed to 
discover new novel compounds of this class with profound 
activities.
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